These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24704464)

  • 1. Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus.
    Grönwall C; Reynolds H; Kim JK; Buyon J; Goldberg JD; Clancy RM; Silverman GJ
    Clin Immunol; 2014 Jul; 153(1):1-7. PubMed ID: 24704464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
    Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
    Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.
    Su J; Frostegård AG; Hua X; Gustafsson T; Jogestrand T; Hafström I; Frostegård J
    J Rheumatol; 2013 Nov; 40(11):1856-64. PubMed ID: 24037548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed serum IgM levels in SLE are restricted to defined subgroups.
    Grönwall C; Hardt U; Gustafsson JT; Elvin K; Jensen-Urstad K; Kvarnström M; Grosso G; Rönnelid J; Padykov L; Gunnarsson I; Silverman GJ; Svenungsson E
    Clin Immunol; 2017 Oct; 183():304-315. PubMed ID: 28919518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.
    Grönwall C; Akhter E; Oh C; Burlingame RW; Petri M; Silverman GJ
    Clin Immunol; 2012 Mar; 142(3):390-8. PubMed ID: 22297166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
    Frerix M; Stegbauer J; Kreuter A; Weiner SM
    Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
    Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
    Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.
    Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ
    J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
    Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
    J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
    McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
    Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural antibodies against phosphorylcholine as potential protective factors in SLE.
    Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegård J
    Rheumatology (Oxford); 2008 Aug; 47(8):1144-50. PubMed ID: 18522961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus.
    Reynolds HR; Buyon J; Kim M; Rivera TL; Izmirly P; Tunick P; Clancy RM
    Atherosclerosis; 2010 Jun; 210(2):569-74. PubMed ID: 20044088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response.
    Diepenhorst GM; Ciurana CL; Diaz Padilla N; Boekholdt SM; Krijnen PA; Lagrand WK; Niessen HW; Hack CE
    Adv Clin Exp Med; 2012; 21(4):455-67. PubMed ID: 23240451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.